Skip to main content

Table 1 (abstract P27). Mean change from baseline for headache day frequency and number of moderate/severe headaches in onabotulinumtoxinA-treated patients with and without a history of medication overuse

From: 12th European Headache Federation Congress jointly with 32nd National Congress of the Italian Society for the Study of Headaches

Variable

Medication Overuse (n=456)

No Medication Overuse (n=259)

Headache day frequency, d, mean (SD)

 Week 60

–10.1 (6.8)

–10.3 (7.6)

 Week 108

–11.4 (7.2)

–12.5 (7.5)

Moderate/severe headache days, d, mean (SD)

 Week 60

–8.8 (6.1)

–8.7 (6.2)

 Week 108

–10.1 (7.0)

–10.0 (7.2)